Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage

被引:15
作者
Liao, Pei-Ju [1 ]
Lin, Tzu-Yu [2 ]
Wang, Tzu-Ching [3 ]
Ting, Ming-Kuo [5 ]
Wu, I-Wen [4 ,6 ]
Huang, Hsin-Tsung [3 ]
Wang, Fu-Chung [3 ]
Chang, Huan-Cheng [7 ,8 ]
Hsu, Kuang-Hung [2 ,8 ]
机构
[1] Oriental Inst Technol, Dept Hlth Care Adm, New Taipei, Taiwan
[2] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan
[3] Minist Hlth & Welf, Natl Hlth Insurance Adm, Taipei, Taiwan
[4] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan
[5] Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Keelung, Taiwan
[6] Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Keelung, Taiwan
[7] Taiwan Landseed Hosp, Dept Med, Div Nephrol, New Taipei, Taiwan
[8] Chang Gung Univ, Dept Hlth Care Management, Taoyuan, Taiwan
关键词
HEALTH-CARE; COST-EFFECTIVENESS; RENAL-DISEASE; IMPACT; OUTCOMES; MANAGEMENT; HYPERTENSION; PREVALENCE; INHIBITORS; DIALYSIS;
D O I
10.1097/MD.0000000000003282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a major health problem worldwide because of the aging population and lifestyle changes. One of the important etiologies of CKD is diabetes mellitus (DM). The long-term effects of pay-for-performance (P4P) on disease progression have not been thoroughly examined. This study is a retrospective population-based patient cohort design to examine the continuous effects of diabetes and CKD P4P interventions. This study used the health insurance claims database to conduct a longitudinal analysis. A total of 32,084 early CKD patients with diabetes were extracted from the outpatient claims database from January 2011 to December 2012, and the follow-up period was extended to August 2014. A 4-group matching design, including both diabetes and early CKD P4P interventions, with only diabetes P4P intervention, with only early CKD P4P intervention, and without any P4P interventions, was performed according to their descending intensity. The primary outcome of this study was all-cause mortality and the causes of death. The statistical methods included a Chi-squared test, ANOVA, and multi-variable Cox regression models. A dose-response relationship between the intervention groups and all-cause mortality was observed as follows: comparing to both diabetes and early CKD P4P interventions (reference), hazard ratio (HR) was 1.22 (95% confidence interval [CI], 1.00-1.50) for patients with only a diabetes P4P intervention; HR was 2.00 (95% CI, 1.66-2.42) for patients with only an early CKD P4P intervention; and HR was 2.42 (95% CI, 2.02-2.91) for patients without any P4P interventions. The leading cause of death of the total diabetic nephropathy patient cohort was infectious diseases (34.32%) followed by cardiovascular diseases (17.12%), acute renal failure (1.50%), and malignant neoplasm of liver (1.40%). Because the earlier interventions have lasting long-term effects on the patient's prognosis regardless of disease course, an integrated early intervention plan is suggested in future care plan designs. The mechanisms regarding the effects of P4P intervention, such as health education on diet control, continuity of care, and practice guidelines and adherence, are the primary components of disease management programs.
引用
收藏
页数:9
相关论文
共 38 条
  • [11] Secondary prevention of cardiovascular disease in different primary healthcare systems with and without pay-for-performance
    Cupples, M. E.
    Byrne, M. C.
    Smith, S. M.
    Leathem, C. S.
    Murphy, A. W.
    [J]. HEART, 2008, 94 (12) : 1594 - 1600
  • [12] Pay-for-performance in disease management: a systematic review of the literature
    de Bruin, Simone R.
    Baan, Caroline A.
    Struijs, Jeroen N.
    [J]. BMC HEALTH SERVICES RESEARCH, 2011, 11
  • [13] Effects of pay for performance in health care: A systematic review of systematic reviews
    Eijkenaar, Frank
    Emmert, Martin
    Scheppach, Manfred
    Schoeffski, Oliver
    [J]. HEALTH POLICY, 2013, 110 (2-3) : 115 - 130
  • [14] The impact of physician bonuses, enhanced fees, and feedback on childhood immunization coverage rates
    Fairbrother, G
    Hanson, KL
    Friedman, S
    Butts, GC
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (02) : 171 - 175
  • [15] Fowler M. J., 2008, CLIN DIABETES, V26, P77, DOI [10.2337/diaclin.26.2.77, DOI 10.2337/DIACLIN.26.2.77]
  • [16] Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563
  • [17] Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis
    Howard, Kirsten
    White, Sarah
    Salkeld, Glenn
    McDonald, Stephen
    Craig, Jonathan C.
    Chadban, Steven
    Cass, Alan
    [J]. VALUE IN HEALTH, 2010, 13 (02) : 196 - 208
  • [18] Huang Jin, 2013, J Evid Based Med, V6, P173, DOI 10.1111/jebm.12052
  • [19] The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5
    Karunaratne, Kushan
    Stevens, Paul
    Irving, Jean
    Hobbs, Helen
    Kilbride, Hannah
    Kingston, Richard
    Farmer, Chris
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (08) : 2107 - 2116
  • [20] Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the national kidney foundation
    Keane, WF
    Eknoyan, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (05) : 1004 - 1010